Page last updated: 2024-08-26

22-hydroxycholesterol and Angiogenesis, Pathologic

22-hydroxycholesterol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bordignon, C; Chiricozzi, E; Ciampa, MG; Daniele, S; Doglioni, C; Eberini, I; Feo, SG; Fontana, R; Gustafsson, JA; Lanterna, C; Leiva, A; Maggioni, D; Martini, C; Mauri, L; Mora, JR; Musumeci, A; Paniccia, A; Prinetti, A; Raccosta, L; Russo, V; Sensi, C; Sonnino, S; Sozzani, S; Steffensen, KR; Traversari, C; Trincavelli, ML; Villablanca, EJ1

Other Studies

1 other study(ies) available for 22-hydroxycholesterol and Angiogenesis, Pathologic

ArticleYear
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils.
    The Journal of experimental medicine, 2013, Aug-26, Volume: 210, Issue:9

    Topics: Animals; Antigens, Ly; CD11b Antigen; Cell Proliferation; Chemotaxis; Chromatography, High Pressure Liquid; Disease Models, Animal; HEK293 Cells; Humans; Hydroxycholesterols; Immunosuppression Therapy; Ligands; Liver X Receptors; Mass Spectrometry; Mice; Myeloid Cells; Neoplasms; Neovascularization, Pathologic; Neutrophils; Orphan Nuclear Receptors; Receptors, G-Protein-Coupled; Receptors, Interleukin-8B; Signal Transduction; Sterols

2013